Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
CPRX: Catalyst Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
CPRX
The Story
CPRX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+23.5% / yr
Operating margin
44.8%
ROIC
19.7%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
7.10×
Valuation
Unrated
P/E ratio
17.5×
Catalyst Pharmaceuticals, Inc.
CPRX
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Catalyst Pharmaceuticals, Inc.
CPRX
NASDAQ
·
USD
·
Closed
$31.49
+0.00%
$31.49
+$0.00 (0.00%)
52W Range
92th
pctl
Volume
-
Mkt Cap
3.85B
USD
P/E
17.5
TTM
Div Yield
–
ann
52W Range
92th
pctl
Volume
-
Market Cap
3.85B
USD
P/E Ratio
17.5
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings